This week, the State Health and Human Services Agency Secretary and the Director of the State Department of Public Health along with the State Public Health Officer issued a joint statement supporting the recommendation by the Western States Scientific Safety Review Workgroup, the U.S. Centers for Disease Control (CDC), the American Academy of Pediatrics and the Federal Food and Drug Administration (FDA) to grant emergency use authorization (EUA) of the Pfizer-BioNTech and Moderna COVID-19 vaccines for children as young as 6 months of age.
Also in California, the Board of Pharmacy sent a notice about reissued pharmacy law waivers in response to Gov. Gavin Newsom’s (D) declaration of emergency and the nation declaration of emergency.
- Staffing Ratio of Pharmacists to Intern Pharmacists and General Supervision and Interprofessional Supervision – Immunizations – BPC section 4114 – The amended expiration date is December 31, 2022, or until 30 days after the emergency declaration is lifted, whichever is sooner.
- Mass Vaccination Sites – The amended expiration date is December 31, 2022, or until 30 days following the declared disaster, whichever is sooner.
- Prescriber Dispensing of COVID-19 Antiviral Medication to an Emergency Room Patient (including BPC sections 4068(a)(1), 4068(a)(5), 4068(a)(6), 4076.5, and 4427.2(a)) – The amended expiration date is 30 days following the end of the declared disaster.
These waivers and all Pharmacy Law waivers are posted under COVID-19 Updates and Resources on the Board’s website.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.